Navigation Links
GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
Date:1/7/2009

ares will cease to be traded on The NASDAQ Capital Market.

About GlaxoSmithKline plc

GlaxoSmithKline plc -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information including a copy of this announcement and details of the company's updated product development pipeline, visit GSK at www.gsk.com.

    Enquiries:
    UK Media enquiries:                  Philip Thomson  (020) 8047 5502
                                         Alice Hunt      (020) 8047 5502
                                         Stephen Rea     (020) 8047 5502

    US Media enquiries:                  Nancy Pekarek    (919) 483 2839
                                         Mary Anne Rhyne  (919) 483 2839
                                         Sarah Alspach    (215) 751 7709
                                         Melinda Stubbee  (215) 751 7709

    European Analyst/Investor enquiries: David Mawdsley  (020) 8047 5564
                                         Sally Ferguson  (020) 8047 5543
                                         Gary Davies     (020) 8047 5503

    US Analyst/ Investor enquiries:      Tom Curry        (215) 751 5419
                                         Jen Hill         (215) 751 7002


'/>"/>
SOURCE GlaxoSmithKline plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
6. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
7. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
8. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
9. GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
10. Vaccinex Antibody Licensed to GlaxoSmithKline
11. Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , SEATTLE, Nov. 19 /PRNewswire-FirstCall...ounced unaudited financial results for the third q...ths ended September 30, 2009, Omeros reported a ne...pared to a net loss of $7.4 million, or $2.54 per ...onths ended September 30, 2009, the Company report...
(Date:11/19/2009)..., , BETHESDA, Md., Nov. 19 /PRNewswire-Fir...an innovator in biotechnology for diabetes therapy...lting services to food, supplement, biotechnology ...results of Tuesday,s Annual Meeting of Shareholder...ncorporated (Nasdaq: SPEX ) elected the following...
(Date:11/19/2009)..., Top LASIK surgeons and ... listed at Trusted LASIK Surgeons made brought the...pments in vision correction surgery, cataract surg...concluded American Academy of Ophthalmology (AAO) ...ichard Lindstrom, Dr. Shachar Tauber, Dr. David Hu...
(Date:11/18/2009)..., , DAVIS, Calif., Nov. 18 ...covery, development and commercialization of effec...nt products, announced that it has been named an I...tates, oldest and largest national angel investing... performance leading to rewarding results for all ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Marrone Bio Innovations Named an IC20 Company 2
...Institute Offers Tips for Coping with the Holiday,...g for millions of women coping with infertility, w...ll of my clients dread Mother,s Day,",says Phyllis...& IVF,Institute (http://www.givf.com ), a compreh...ax, VA. "Women who are distressed by Mother,s Day ...
...s., May 9 Millstone Medical Outsourcing,announced...ISO 13485,certified quality system to the Memphis,...r Standardization, is the world,s largest develope...dition, the company hired Gary,Stevens, a highly-e...anager,for the Memphis location. Millstone, outsou...
...., May 9 InterMune, Inc.,(Nasdaq: ITMN ) today a...tive Officer of InterMune, will present at the Ban...gas on May 14, 2008 at 9:20 a.m. PDT (12:20,p.m ED...tation, investors and other,interested parties may...e,s,corporate website at http://www.intermune.com...
Other Biology Technology:Mother's Day is Devastating for Women Facing Infertility 2Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager 2
(Date:11/19/2009)...ing brain chemical with an unwieldy name: 4-hydrox... or used as a date-rape drug. , Now, a team of ...outes by which 4-HB is metabolized by the body. "T...hael Gibson, professor and chair of biological sci...ember of the research team. "It may provide new c...
(Date:11/19/2009)...rop in many countries of the world. It is widely u...rial materials. It also is considered an exemplar ...r evolution, and genome architecture. The authors ...on used the first description of the B73 maize gen... in genetics and plant biology. The ten papers con...
(Date:11/19/2009)..., Nov. 19 BIO-key Intern... in wireless public safety and finger-based biomet...pecial Shareholder Meeting held today was adjourne...was not present. ,, (Logo: http://www.newscom....an impressive 99.3% of the 35 million votes cast v...
Breaking Biology News(10 mins):Researchers begin to decipher metabolism of sexual assault drug 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 1Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 2Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 3Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 4Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 5Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 1Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 2Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 3AEterna Zentaris Partner Keryx Biopharmaceuticals Receives Orphan Drug Designation for Perifosine 28KRX 0401 29 for the Treatment of Multiple Myelo 14093 1AEterna Zentaris Partner Keryx Biopharmaceuticals Receives Orphan Drug Designation for Perifosine 28KRX 0401 29 for the Treatment of Multiple Myelo 14093 2AEterna Zentaris Partner Keryx Biopharmaceuticals Receives Orphan Drug Designation for Perifosine 28KRX 0401 29 for the Treatment of Multiple Myelo 14093 3
...Scientists are on the trail of Iapetus, mysterious...unaway, process that is transporting vaporised wat...he Saturnian moon. , This ,thermal segregation, m...e and dramatically two-toned appearance, which hav...ected during Cassinis recent close fly-by of Iapet...
... , From 135,000 to 90,000 years ago tropical Afri...an any previously known for that region, according...al Africa was an arid scrubland during the early L... migration out of Africa and the evolution of fish...of the deepest lakes in the world, acts as a rain ...
...ne day soon, laboratories may grow synthetically e...ed for transplants. In a major step forward, Corne...ials a microvascular system they have developed t...have engineered tiny channels within a water-based...scale and can supply oxygen, essential nutrients a...
Other Biology News:Cassini on the trail of a runaway mystery 2Cassini on the trail of a runaway mystery 3Newfound ancient African megadroughts may have driven the evolution of humans and fishes 2Newfound ancient African megadroughts may have driven the evolution of humans and fishes 3Newfound ancient African megadroughts may have driven the evolution of humans and fishes 4Researchers create system to build transplant tissue 2
EGTA; AM; 10mM DMSO solution from AnaSpec
Rat Anti-Rat RT1Au (Class I Polymorphic) Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Human c-myc, aa 171-188 Monoclonal Antibody, Unconjugated, Clone 3C7 from AbD Serotec
Rabbit Anti-NEOPTERIN Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: